NV1FGF Gene Therapy on Amputation-Free Survival in Critical Limb Ischemia - TAMARIS


The goal of the trial was to evaluate treatment with NV1FGF gene therapy compared with placebo among patients with critical limb ischemia.

NV1FGF is a nonviral recombinant DNA plasmid, containing a gene encoding FGF1, which promotes proliferation of vascular cells.